Extrapolating the current growth in Germany, specialist search engine Viomedo could reach 100,000 monthly users in the beginning of 2017. Being fully operational for only half a year, this would be a sign for nothing less than – as Viomedo’s pharma partners would call it – a huge unmet need.
mAb ray of hope for Alzheimer’s
Latest News01.09.2016 – The causes of Alzheimer’s disease are still largely unknown. But now, an antibody developed by the University of Zurich has significantly reduced the brain amyloid plaques typical for Alzheimer’s Disease in a Phase Ib clinical trial.
Ferring bags slipped disk pain drug
Latest News30.08.2016 – Swiss biopharma company Ferring has acquired the exclusive development and commercialisation rights to Seikagaku’s Phase III chemonucleolytic leg pain treatment for €85m.
Vaccine pro
AppointmentsBrussels-based vaccine developer Univac has appointed a new CEO. In March, Stefano Malvolti joined Univac from Gavi, the Vaccine Alliance, where he was responsible for rolling out the vaccine development programmes of the public-private partnership.
Phase III washout for Adocia
Latest NewsAdocia said it would discontinue its diabetic foot ulcer programme after its lead product BioChaperone PDGF disappointed in Phase III. The French company will turn the focus on its earlier-stage products.
AZ unloads antibiotics to Pfizer
Latest News24.08.2016 – Pharma major Pfizer is putting the cherry on top of its multi-billion-dollar takeover of Medivation with the acquisition of AstraZeneca’s antibiotics for a cool US$1.5bn. With the divestment, AZ aims to further sharpen its focus.
Pharma exec
AppointmentsFaron Pharmaceuticals has someone new to oversee its drug development strategy. In early May, the Turku-based clinical stage biopharma company appointed Matti Karvonen as its new Medical Director.
€87m for Cambridge Cluster fund
Latest News23.08.2016 – Cambridge University-allied investor Cambridge Innovation Capital has raised £75m (€87m) to reinvest in technology and healthcare companies. Among the backers were Woodford Investment and Winton Ventures.
FILTRODISC BIO SD
ProductsFILTRODISC BIO SD is a filtration system which removes particles (e.g. cells, bacteria, yeast), impurities (e.g. HCP, DNA) and other turbid matter from process liquids (e.g. fermentation broths).
Priority review for Genmab’s Darzalex?
Latest News19.08.2016 – Together with partner Johnson & Johnson, Danish biotech Genmab is now one step closer to FDA approval with its combination treatment for multiple myeloma after its submission of a supplemental Biologics License Application. In July, Genmab was granted a Breakthrough Therapy Designation (BTD) for its blood cancer therapy.
Study search engine going strong
ProductsExtrapolating the current growth in Germany, specialist search engine Viomedo could reach 100,000 monthly users in the beginning of 2017. Being fully operational for only half a year, this would be a sign for nothing less than – as Viomedo’s pharma partners would call it – a huge unmet need.